Oct 26, 2022 0 NovaBay Pharmaceuticals Announces Expansion of DERMAdoctor Picture Porefect Collection with Launch of 15% Niacinamide Pore Minimizing Serum
Oct 18, 2022 0 NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor’s Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season
Oct 10, 2022 0 NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale
Sep 23, 2022 0 NovaBay Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conference
Sep 12, 2022 0 NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor’s Eczema Balm on Return QVC® Appearance
Sep 09, 2022 0 NovaBay Pharmaceuticals Enters Into Agreements For a Private Placement and Warrant Reprice Transactions To Raise Up to $5.3 Million
Jul 28, 2022 0 NovaBay Pharmaceuticals Targets New Market with Antimicrobial Avenova® Lid and Lash Spray for Lash Extensions
Jul 21, 2022 0 NovaBay Pharmaceuticals’ DERMAdoctor Products Now Available at Target.com and Urbanoutfitters.com
Jul 07, 2022 0 NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America
Apr 11, 2022 0 NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor’s Eczema Treatment
Apr 01, 2022 0 NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line
Mar 22, 2022 0 NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29
Feb 28, 2022 0 NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air Guest
Feb 23, 2022 0 NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Products in China
Jan 20, 2022 0 NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Jan 10, 2022 0 NovaBay Pharmaceuticals Expands its Eyecare Product Portfolio with the Launch of Lubricating Eye Drops for the Immediate Relief of Dry Eye Symptoms
Dec 13, 2021 0 DERMAdoctor’s Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance
Sep 29, 2021 0 NovaBay Pharmaceuticals to Hold Conference Call and Webcast with Slide Presentation Today to Discuss Acquisition of DERMAdoctor
Sep 08, 2021 0 NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference
Jul 19, 2021 0 NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
Mar 31, 2021 0 NovaBay Pharmaceuticals’ Avenova® Warm Eye Compress for the Relief of Symptoms Associated with Dry Eye is Now Available on Amazon.com and Avenova.com
Mar 18, 2021 0 NovaBay Pharmaceuticals to Hold 2020 Fourth Quarter and Full Year Conference Call on March 25
Nov 23, 2020 0 NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement
Sep 24, 2020 0 NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public Relations
Apr 20, 2020 0 NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals
Mar 25, 2020 0 NovaBay Pharmaceuticals Announces the Availability of KN95 Disposable Masks on Avenova.com
Mar 23, 2020 0 NovaBay Pharmaceuticals Unveils Refreshed Consumer Branding for Online Sales of Avenova® Antimicrobial Lid & Lash Solution
Mar 19, 2020 0 NovaBay Pharmaceuticals to Hold 2019 Fourth Quarter and Full Year Conference Call on March 26, 2020
Nov 18, 2019 0 NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com
Nov 04, 2019 0 NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures
Oct 31, 2019 0 NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019
Oct 28, 2019 0 NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies
Aug 09, 2019 0 NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock
Apr 17, 2019 0 NovaBay Pharmaceuticals Announces Annual Meeting of Stockholders and Receives NYSE American Communication
Apr 01, 2019 0 NovaBay Pharmaceuticals Announces Investments of $5 Million to Support U.S. Avenova Commercialization Strategy
Mar 12, 2019 0 NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
Jan 07, 2019 0 NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance
